Zimmer Biomet Holdings Inc (NYSE:ZBH) Sellers Rose Their Shorts By 4.87%

June 29, 2018 - By Michael Higginson

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Corporate Logo

Zimmer Biomet Holdings Inc (NYSE:ZBH) had an increase of its shorted shares by 4.87%. FINRA announced in June ZBH’s total 3.56M shorted shares. That’s 4.87% up from 3.40 million shares. Zimmer Biomet Holdings Inc (NYSE:ZBH) has 1.58 million shares average volume. It’ll cost 2 days for ZBH to recover its previous position. Float short on Zimmer Biomet Holdings Inc is 1.76%.

ZBH is touching $112.92 during the last trading session, after increased 1.48%.Zimmer Biomet Holdings, Inc. has volume of 268,906 shares. Since June 29, 2017 ZBH has declined 6.89% and is downtrending. ZBH underperformed by 19.46% the S&P500.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, makes, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.The company has $22.95 billion market cap. It operates through four divisions: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic , and Dental.The P/E ratio is 13.65. The firm provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Ratings Coverage

A total of 17 analysts rate Zimmer Biomet Holdings (NYSE:ZBH) as follows: 11 “Buy”, 5 “Hold” and 1 “Sell”. Тherefore 65% are bullish. (NYSE:ZBH) has 22 ratings reports on Jun 29, 2018 according to StockzIntelligence. On Friday, June 22 Argus Research downgraded the shares of ZBH in report to “Hold” rating. On Friday, March 23 the firm earned “Neutral” rating by Robert W. Baird. On Thursday, April 26 Canaccord Genuity maintained the shares of ZBH in report with “Hold” rating. On Tuesday, January 30 the stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has “Buy” rating given by Robert W. Baird. On Friday, April 27 the stock has “Buy” rating by Needham. On Wednesday, January 31 the firm has “Buy” rating given by Guggenheim. On Tuesday, January 30 the firm has “Buy” rating by Jefferies given. In Tuesday, January 30 report Needham maintained the stock with “Buy” rating. On Friday, April 27 the company was maintained by JMP Securities. On Monday, February 26 Morgan Stanley maintained the shares of ZBH in report with “Overweight” rating.

A couple more Zimmer Biomet Holdings, Inc. (NYSE:ZBH) news were released by: Benzinga.com which released on June 24, 2018 “Benzinga’s Bulls & Bears Of The Week: AMD, Disney, Nike, Tesla And More”, also Benzinga.com on June 22, 2018 released “Argus Drops Bullish Zimmer Biomet Thesis On Manufacturing, Supply, Sales Worries”, the next Benzinga.com is “Benzinga’s Top Upgrades, Downgrades For June 22, 2018” on June 22, 2018. Seekingalpha.com has article titled “Medical device makers ISRG, BSX, ABT started with bullish view at Bernstein”.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: